Overview

Evaluation of Intranasal Naltrexone and Naloxone

Status:
Completed

Trial end date:
2015-11-07

Target enrollment:

Participant gender:

Summary

This study will be to determine the pharmacokinetics of naltrexone and naloxone when administered via intranasal separately and in combination in healthy volunteers.

Phase:

Phase 1

Details

Lead Sponsor:

National Institute on Drug Abuse (NIDA)

Treatments:

Naloxone
Naltrexone